Paper41746934
Designing a novel vaccine against COVID-19 based on spike SARS-Cov-2 notable mutations using immunoinformatics approaches.
Rahimnahal S and 2 others. PLoS One, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Designing a novel vaccine against COVID-19 based on spike SARS-Cov-2 notable mutations using immunoinformatics approaches. Papers, record 41746934. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41746934
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Designing a novel vaccine against COVID-19 based on spike SARS-Cov-2 notable mutations using immunoinformatics approaches.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| SARS-CoV-2 | Major topic |
| Spike Glycoprotein, Coronavirus | Major topic |
| COVID-19 Vaccines | Major topic |
| COVID-19 | Major topic |
| Immunoinformatics | |
| Humans | |
| Mutation | |
| Epitopes, T-Lymphocyte | |
| Molecular Docking Simulation | |
| Epitopes, B-Lymphocyte | |
| Protein Subunit Vaccines |
Source PubMed
References153
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37196033 | Spike substitution T813S increases Sarbecovirus fusogenicity by enhancing the usage of TMPRSS2. | PLoS Pathog | 2023 | https://conductscience.org/library/papers/37196033 | PubMed |
| 2 | 35074895 | Thiol-based chemical probes exhibit antiviral activity against SARS-CoV-2 via allosteric disulfide disruption in the spike glycoprotein. | Proc Natl Acad Sci U S A | 2022 | https://conductscience.org/library/papers/35074895 | PubMed |
| 3 | 32065055 | Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. | Emerg Microbes Infect | 2020 | https://conductscience.org/library/papers/32065055 | PubMed |
| 4 | 35474907 | SARS-CoV-2 mutations acquired during serial passage in human cell lines are consistent with several of those found in recent natural SARS-CoV-2 variants. | Comput Struct Biotechnol J | 2022 | https://conductscience.org/library/papers/35474907 | PubMed |
| 5 | 35128175 | Highlight of potential impact of new viral genotypes of SARS-CoV-2 on vaccines and anti-viral therapeutics. | Gene Rep | 2022 | https://conductscience.org/library/papers/35128175 | PubMed |
| 6 | 32007145 | Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. | Lancet | 2020 | https://conductscience.org/library/papers/32007145 | PubMed |
| 7 | 35004593 | Analysis of Clinical Characteristics and Virus Strains Variation of Patients Infected With SARS-CoV-2 in Jiangsu Province-A Retrospective Study. | Front Public Health | 2021 | https://conductscience.org/library/papers/35004593 | PubMed |
| 8 | 33106671 | Spike mutation D614G alters SARS-CoV-2 fitness. | Nature | 2021 | https://conductscience.org/library/papers/33106671 | PubMed |
| 9 | 34400835 | SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution. | Nat Microbiol | 2021 | https://conductscience.org/library/papers/34400835 | PubMed |
| 10 | 12551991 | Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E. | J Virol | 2003 | https://conductscience.org/library/papers/12551991 | PubMed |
| 11 | 8241910 | Respiratory viruses and exacerbations of asthma in adults. | BMJ | 1993 | https://conductscience.org/library/papers/8241910 | PubMed |
| 12 | 22615877 | The adjuvanticity of an O. volvulus-derived rOv-ASP-1 protein in mice using sequential vaccinations and in non-human primates. | PLoS One | 2012 | https://conductscience.org/library/papers/22615877 | PubMed |
| 13 | 33547453 | Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA. | Nat Hum Behav | 2021 | https://conductscience.org/library/papers/33547453 | PubMed |
| 14 | 34168070 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants. | Science | 2021 | https://conductscience.org/library/papers/34168070 | PubMed |
| 15 | 33882225 | Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. | N Engl J Med | 2021 | https://conductscience.org/library/papers/33882225 | PubMed |
| 16 | 33127862 | Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area. | mBio | 2020 | https://conductscience.org/library/papers/33127862 | PubMed |
| 17 | 33352214 | A comprehensive screening of the whole proteome of hantavirus and designing a multi-epitope subunit vaccine for cross-protection against hantavirus: Structural vaccinology and immunoinformatics study. | Microb Pathog | 2021 | https://conductscience.org/library/papers/33352214 | PubMed |
| 18 | 34818667 | The N501Y spike substitution enhances SARS-CoV-2 infection and transmission. | Nature | 2022 | https://conductscience.org/library/papers/34818667 | PubMed |
| 19 | 35864211 | Mutational induction in SARS-CoV-2 major lineages by experimental exposure to neutralising sera. | Sci Rep | 2022 | https://conductscience.org/library/papers/35864211 | PubMed |
| 20 | 36586276 | Reverse vaccinology assisted design of a novel multi-epitope vaccine to target Wuchereria bancrofti cystatin: An immunoinformatics approach. | Int Immunopharmacol | 2023 | https://conductscience.org/library/papers/36586276 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42774152 | Multi-epitope vaccine targeting SARS-CoV-2 omicron S and N proteins promotes enhanced immunity: a computational approach. | Front Immunol | 2026 | https://conductscience.org/library/papers/42774152 |
Source PubMed
Genes20
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41746934
GET https://conductscience.org/api/papers/v1/41746934/references?page=2